Table 5. SIRs of SPMs in colon and rectal cancer patients, by stage.
| SPMs | Colon | Rectum | ||||
|---|---|---|---|---|---|---|
| Localized | Regional | Distant | Localized | Regional | Distant | |
| All sites | 1.19* | 1.19* | 1.16* | 1.13* | 1.01 | 0.99 |
| Esophagus | 1.36* | 1.07 | 0.38 | 0.81 | 1.68* | 0.47 |
| Stomach | 1.42* | 1.11 | 0.96 | 1.12 | 0.84 | 1.11 |
| Small intestine | 3.06* | 6.22* | 10.01* | 1.50 | 3.42* | 0 |
| Colon | 1.87* | 2.31* | 3.13* | 1.37* | 1.58* | 1.95* |
| Rectosigmoid junction and rectum | 1.59* | 2.51* | 4.64* | 4.60* | 2.92* | 3.58* |
| Liver | 1.06 | 0.83 | 0.93 | 0.98 | 1.10 | 0.30 |
| Gallbladder | 0.92 | 0.72 | 0.73 | 0.60 | 1.53 | 0 |
| Pancreas | 1.07 | 1.04 | 1.19 | 1.02 | 0.91 | 0.76 |
| Lung and bronchus | 1.18* | 1.13* | 0.84 | 1.12* | 1.05 | 0.94 |
| Female breast | 1.05 | 0.99 | 0.68* | 0.94 | 0.87 | 0.79 |
| Cervix uteri | 1.13 | 1.08 | 1.01 | 0.65 | 1.29 | 2.79 |
| Corpus uteri | 1.47* | 1.40* | 2.30* | 1.09 | 1.66* | 0.51 |
| Ovary | 0.78 | 0.67* | 0.86 | 0.81 | 0.54 | 2.00 |
| Prostate | 1.13* | 1.03 | 0.71* | 0.85* | 0.46* | 0.55* |
| Kidney | 1.29* | 1.02 | 1.05 | 1.00 | 1.09 | 0.92 |
| Urinary bladder | 1.05 | 0.98 | 1.21 | 1.12 | 1.10 | 0.92 |
| Brain | 1.05 | 0.76 | 0 | 1.00 | 0.81 | 1.10 |
| Thyroid | 1.74* | 1.51* | 1.85 | 1.49* | 2.30* | 0.80 |
| Bones and joints | 0.70 | 1.67 | 0 | 0.96 | 0.78 | 5.61 |
| Soft tissue including heart | 1.00 | 1.12 | 1.19 | 1.80* | 1.42 | 0 |
| All lymphatic and hematopoietic diseases | 0.95 | 0.90* | 0.46* | 1.00 | 0.76* | 0.76 |
| Others | 1.02 | 0.92 | 0.90 | 1.06 | 0.99 | 1.22 |
*P<0.05